United States · 
Who invested in Actio Biosciences?
Actio Biosciences's investors include Canaan and Deerfield.
United States · Series B startup
Who invested in Actio Biosciences
Funding summaryUpdated 26 Oct 2026
$66Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $66MJun 2025
- Investors
- 2
The rounds
- Jun 2025
Founders and team
From Actio Biosciences's own website: 2 on the team.
- Cayce DentonChief Financial Officer
- Pete CondonChief Business Officer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Actio Biosciences
How much has Actio Biosciences raised?
Actio Biosciences has raised $66M across 1 round since 2025.
When did Actio Biosciences last raise?
Actio Biosciences's most recent round was a Series B of $66M in Jun 2025.
What was Actio Biosciences's biggest round?
Its most recent round, $66M in Jun 2025, is also its largest on record.
Who backed Actio Biosciences first?
Actio Biosciences's first round on record, in Jun 2025, was backed by Canaan and Deerfield.
What stage is Actio Biosciences at?
Actio Biosciences's latest named round is a Series B, in Jun 2025.
Where is Actio Biosciences based?
Actio Biosciences is based in the United States.
Companies like Actio Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.